ATE266397T1 - Verfahren zur förderung des haarwuchses und entwicklung des haarsystems - Google Patents
Verfahren zur förderung des haarwuchses und entwicklung des haarsystemsInfo
- Publication number
- ATE266397T1 ATE266397T1 AT98904968T AT98904968T ATE266397T1 AT E266397 T1 ATE266397 T1 AT E266397T1 AT 98904968 T AT98904968 T AT 98904968T AT 98904968 T AT98904968 T AT 98904968T AT E266397 T1 ATE266397 T1 AT E266397T1
- Authority
- AT
- Austria
- Prior art keywords
- hair
- development
- growth
- promoting
- hair growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3723797P | 1997-02-04 | 1997-02-04 | |
PCT/US1998/002289 WO1998033497A1 (en) | 1997-02-04 | 1998-02-03 | Method of enhancing hair growth |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE266397T1 true ATE266397T1 (de) | 2004-05-15 |
Family
ID=21893222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98904968T ATE266397T1 (de) | 1997-02-04 | 1998-02-03 | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems |
Country Status (8)
Country | Link |
---|---|
US (1) | US6262105B1 (de) |
EP (1) | EP1021179B1 (de) |
JP (2) | JP4397973B2 (de) |
AT (1) | ATE266397T1 (de) |
AU (1) | AU750039B2 (de) |
CA (1) | CA2279967C (de) |
DE (1) | DE69823852T2 (de) |
WO (1) | WO1998033497A1 (de) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69823852T2 (de) | 1997-02-04 | 2005-05-19 | Johnstone, Murray A., Seattle | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems |
EP1159266B1 (de) | 1999-03-05 | 2004-11-03 | Duke University | C-16 ungesätigte fp-selektive prostaglandin analoge |
JP4162823B2 (ja) * | 2000-01-07 | 2008-10-08 | 花王株式会社 | 頭髪用化粧料 |
US6579542B1 (en) * | 2000-03-02 | 2003-06-17 | Cecil Faulkner | Treating feline-specific disorders by orally administering Hydrastis canadensis |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
FR2812190B1 (fr) * | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
FR2812191B1 (fr) * | 2000-07-28 | 2003-10-17 | Oreal | Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques |
FR2812192B1 (fr) * | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
FR2812193B1 (fr) * | 2000-07-28 | 2003-10-24 | Oreal | Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques |
CA2449462A1 (en) * | 2001-07-25 | 2003-02-06 | Alcon, Inc. | Methods for promotion of hair growth comprising topical application of prostaglandin analogues |
US8758733B2 (en) | 2002-02-04 | 2014-06-24 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
US9216183B2 (en) | 2002-02-04 | 2015-12-22 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
US7351404B2 (en) * | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
AU2012261499B2 (en) * | 2002-02-04 | 2016-05-12 | Allergan, Inc. | Method of enhancing hair growth |
CA2482711A1 (fr) * | 2002-04-23 | 2003-11-06 | L'oreal | Composition cosmetique pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux |
US7320967B2 (en) * | 2002-04-23 | 2008-01-22 | L'oreal | Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair |
US20030199590A1 (en) * | 2002-07-25 | 2003-10-23 | Cagle Gerald D | Prostaglandin analogues for promotion of hair growth |
US20040115234A1 (en) * | 2002-09-24 | 2004-06-17 | Gewirtz Joan T. | Cosmetic composition |
US7326717B2 (en) | 2003-05-06 | 2008-02-05 | L'oreal | Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
TWI495471B (zh) * | 2003-08-12 | 2015-08-11 | R Tech Ueno Ltd | 促進毛髮生長之組成物及方法 |
US20050058614A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides |
KR20070090218A (ko) * | 2004-12-29 | 2007-09-05 | 가부시키가이샤 아루떼꾸 우에노 | 두피 및 모발 치료용 조성물 및 치료 방법 |
CN101160114B (zh) * | 2004-12-29 | 2013-02-06 | 株式会社·R-技术上野 | 头皮和毛发处理组合物及方法 |
US20060177403A1 (en) * | 2005-02-08 | 2006-08-10 | L'oreal | Cosmetic/dermatological compositions comprising a derivative of glucose and of vitamin F and A specific surfactant |
US20070009468A1 (en) * | 2005-05-12 | 2007-01-11 | Bernstein Eric F | Photodynamic method of inducing the growth of hair |
WO2007023841A1 (ja) * | 2005-08-25 | 2007-03-01 | Taisho Pharmaceutical Co., Ltd. | 発毛剤組成物 |
CA2681668C (en) | 2006-03-23 | 2014-04-01 | Michael S. Singer | Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat |
US7879910B1 (en) | 2006-10-10 | 2011-02-01 | Jan Marini Skin Research, Inc. | Compositions and methods for promoting lush hair growth |
FR2916350B1 (fr) * | 2007-05-22 | 2009-07-24 | Oreal | Utilisation d'agonistes du recepteur du thromboxame pour moduler la croissance pilaire |
US20090018204A1 (en) * | 2007-07-13 | 2009-01-15 | Brinkenhoff Michael C | Composition and method for enhancing hair growth |
FR2920309B1 (fr) | 2007-08-28 | 2010-05-28 | Galderma Res & Dev | Utilisation de travoprost pour traiter la chute des cheveux |
US20100074857A1 (en) * | 2008-09-23 | 2010-03-25 | Pamela Lipkin | Compositions and methods to treat epithelial-related conditions |
WO2009058493A1 (en) * | 2007-10-31 | 2009-05-07 | Pamela Lipkin | Prostaglandin analog compositions and methods to treat epithelial-related conditions |
US8455547B2 (en) * | 2008-02-05 | 2013-06-04 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
US7964596B2 (en) * | 2008-03-07 | 2011-06-21 | Allergan, Inc. | Therapeutic compounds |
EP2288333B1 (de) | 2008-05-14 | 2011-12-28 | Peter Thomas Roth Labs, Llc | Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung |
US20080275118A1 (en) * | 2008-06-12 | 2008-11-06 | Shaw Mari M | Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss |
SG193840A1 (en) * | 2008-09-04 | 2013-10-30 | Santen Pharmaceutical Co Ltd | HAIR GROWTH PROMOTING AGENT CONTAINING 15,15-DIFLUOROPROSTAGLANDIN F2a DERIVATIVE AS ACTIVE INGREDIENT |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US20100204335A1 (en) * | 2008-12-01 | 2010-08-12 | Allergan, Inc. | Kit and composition for eyelash growth |
WO2010064203A1 (en) | 2008-12-02 | 2010-06-10 | L'oreal | Combination of reduced glutathione and amino acids for improving the quality of the hair in women |
FR2941150B1 (fr) * | 2009-01-16 | 2013-01-11 | Oreal | Produit pour la prevention ou le traitement du blanchissement des cheveux. |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
WO2010138422A1 (en) * | 2009-05-27 | 2010-12-02 | Allergan, Inc. | Cyclosporin derivatives for enhancing the growth of hair |
FR2949052B1 (fr) | 2009-08-13 | 2015-03-27 | Oreal | Procede de traitement cosmetique du cuir chevelu. |
CA2780925A1 (en) * | 2009-11-09 | 2011-05-12 | Allergan, Inc. | Compositions for enhancing hair growth |
WO2011057129A2 (en) | 2009-11-09 | 2011-05-12 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
US9149484B2 (en) | 2009-11-09 | 2015-10-06 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
BR112013002584A2 (pt) | 2010-08-02 | 2016-06-07 | Pharma Patent Holding Inc | composição, processo de kit para aperfeiçoamento de cabelo |
JP2014500275A (ja) * | 2010-12-06 | 2014-01-09 | フォリカ,インコーポレイテッド | 禿頭症を治療するため、および毛髪の成長を促進するための方法 |
EP3378480A1 (de) | 2011-01-19 | 2018-09-26 | Topokine Therapeutics, Inc. | Verfahren und zusammensetzungen zur behandlung des stoffwechselsyndroms |
US8859616B2 (en) | 2011-01-21 | 2014-10-14 | Allergan, Inc. | Compounds and methods for enhancing hair growth |
JP2014516083A (ja) * | 2011-06-08 | 2014-07-07 | エスケー ケミカルズ カンパニー,リミテッド | まつ毛成長用組成物 |
US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
PL2838533T3 (pl) | 2012-04-16 | 2018-03-30 | Case Western Reserve University | Kompozycje i sposoby modulowania aktywności 15-PGDH |
EP2857002A4 (de) * | 2012-05-30 | 2015-12-09 | Asahi Glass Co Ltd | Zusammensetzung für haarwachstum |
US9987213B2 (en) | 2012-06-13 | 2018-06-05 | Edward Dunne Corboy, JR. | Topical dihydrotestosterone (DHT) for promoting hair growth—containing formulations |
US8778981B2 (en) | 2012-11-21 | 2014-07-15 | Topokine Therapeutics, Inc. | Methods and compositions for locally increasing body fat |
NO2753788T3 (de) | 2013-05-10 | 2018-06-16 | ||
US9820993B2 (en) | 2013-05-15 | 2017-11-21 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
EP3057973B1 (de) | 2013-10-15 | 2019-09-04 | Case Western Reserve University | Zusammensetzungen mit einem 15-pgdh-hemmer zur wundheilung |
WO2015200425A1 (en) | 2014-06-27 | 2015-12-30 | Topokine Therapeutics, Inc. | Topical dosage regimen |
AU2016229918B2 (en) | 2015-03-08 | 2020-10-29 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for treating fibrosis |
US11690847B2 (en) | 2016-11-30 | 2023-07-04 | Case Western Reserve University | Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof |
AU2018215678A1 (en) | 2017-02-06 | 2019-08-22 | Board Of Regents Of The University Of Texas System | Compositions and methods of modulating short-chain dehydrogenase activity |
KR20210119954A (ko) | 2018-11-21 | 2021-10-06 | 케이스 웨스턴 리저브 유니버시티 | 단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법 |
FR3089413B1 (fr) | 2018-12-06 | 2021-02-19 | Fabre Pierre Dermo Cosmetique | Extrait de Garcinia mangostana pour promouvoir la croissance capillaire |
WO2020263115A1 (ru) | 2019-06-28 | 2020-12-30 | Общество С Ограниченной Ответственностью "Регеус" | Средство для усиления роста волос |
FR3099699A1 (fr) | 2019-08-06 | 2021-02-12 | Pierre Fabre Dermo-Cosmetique | Extrait d’akènes de Silybum marianum (L.) Gaertn. pour promouvoir la croissance capillaire |
JP2022543532A (ja) | 2019-08-07 | 2022-10-13 | アネイラ・ファーマ・インコーポレイテッド | 脱毛の治療のための組成物 |
CN114206344A (zh) | 2019-08-09 | 2022-03-18 | 诺瓦利克有限责任公司 | 包含前列腺素类似物的局部组合物 |
EP3895685A1 (de) | 2020-04-14 | 2021-10-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Natürliche zusammensetzung zur haarwachstumsstimulation und haarverlustverhinderung und behandlung ohne konservierungsmittel |
EP3895686A1 (de) | 2020-04-14 | 2021-10-20 | FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. | Natürliche zusammensetzung zur stimulierung des haarwuchses und zur vorbeugung und behandlung von haarausfall |
PE20230777A1 (es) | 2020-05-20 | 2023-05-09 | Rodeo Therapeutics Corp | Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta |
JP7141025B1 (ja) * | 2021-11-11 | 2022-09-22 | エルデシエロ プライベート リミテッド | 化合物、組成物、方法、及び製造方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4139619A (en) | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
US4311707A (en) | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
US4599353A (en) | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
ZA855740B (en) | 1984-07-31 | 1987-03-25 | Syntex Inc | 11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives |
JPS61218510A (ja) * | 1985-03-22 | 1986-09-29 | Dai Ichi Seiyaku Co Ltd | 毛髪用剤 |
US4883819A (en) | 1986-07-31 | 1989-11-28 | The Trustees Of Columbia University In The City Of New York | Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma |
US4824857A (en) | 1986-05-16 | 1989-04-25 | Yasumasa Goh | Use of prostaglandin D2 -active substances |
US4952581A (en) | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
ES2052735T3 (es) | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
SE8703854D0 (sv) | 1987-10-07 | 1987-10-07 | Pharmacia Ab | Prostaglandinderivat for behandling av glaukom eller okuler hypertension |
US5321128A (en) | 1988-09-06 | 1994-06-14 | Kabi Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
EP0569046B1 (de) | 1988-09-06 | 2002-11-13 | Pharmacia Aktiebolag | Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension |
US4968812A (en) | 1989-06-23 | 1990-11-06 | Shell Oil Company | Spirolactonelactams |
JPH0737390B2 (ja) * | 1989-08-29 | 1995-04-26 | 久光製薬株式会社 | 軟膏組成物 |
JPH0737389B2 (ja) * | 1989-08-29 | 1995-04-26 | 久光製薬株式会社 | プロスタグランジンe1含有の軟膏剤 |
US5288754A (en) | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
JP3102141B2 (ja) * | 1992-05-29 | 2000-10-23 | 東レ株式会社 | 養毛育毛剤 |
US5352708A (en) | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US6248751B1 (en) * | 1993-05-28 | 2001-06-19 | Gurpreet S. Ahluwalia | Inhibition of hair growth |
FR2711060B1 (fr) * | 1993-10-13 | 1995-11-17 | Oreal | Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet. |
SE9303444D0 (sv) * | 1993-10-20 | 1993-10-20 | Kabi Pharmacia Ab | New use of prostaglandins |
DE69823852T2 (de) | 1997-02-04 | 2005-05-19 | Johnstone, Murray A., Seattle | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems |
-
1998
- 1998-02-03 DE DE69823852T patent/DE69823852T2/de not_active Expired - Lifetime
- 1998-02-03 WO PCT/US1998/002289 patent/WO1998033497A1/en active IP Right Grant
- 1998-02-03 AU AU62709/98A patent/AU750039B2/en not_active Expired
- 1998-02-03 JP JP53324898A patent/JP4397973B2/ja not_active Expired - Lifetime
- 1998-02-03 EP EP98904968A patent/EP1021179B1/de not_active Expired - Lifetime
- 1998-02-03 AT AT98904968T patent/ATE266397T1/de not_active IP Right Cessation
- 1998-02-03 CA CA002279967A patent/CA2279967C/en not_active Expired - Lifetime
-
1999
- 1999-08-03 US US09/366,656 patent/US6262105B1/en not_active Expired - Lifetime
-
2008
- 2008-12-02 JP JP2008307929A patent/JP2009102336A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1021179A4 (de) | 2001-04-04 |
EP1021179A1 (de) | 2000-07-26 |
EP1021179B1 (de) | 2004-05-12 |
AU6270998A (en) | 1998-08-25 |
US6262105B1 (en) | 2001-07-17 |
CA2279967C (en) | 2006-08-22 |
AU750039B2 (en) | 2002-07-11 |
DE69823852T2 (de) | 2005-05-19 |
JP2001511155A (ja) | 2001-08-07 |
JP4397973B2 (ja) | 2010-01-13 |
JP2009102336A (ja) | 2009-05-14 |
DE69823852D1 (de) | 2004-06-17 |
CA2279967A1 (en) | 1998-08-06 |
WO1998033497A1 (en) | 1998-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE266397T1 (de) | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems | |
ES2100534T3 (es) | Dispositivo de extension de tejido vivo. | |
DE69829336D1 (de) | Vorrichtung und Verfahren zur Behandlung von Körpergewebe | |
DE69829921D1 (de) | Vorrichtung zur Behandlung von Körpergewebe | |
DE59102667D1 (de) | Mittel zum reduzieren des wachstums bzw. entfernen der haare am menschlichen körper. | |
ATE296083T1 (de) | Verfahren zur förderung der haar-, nagel-, hautkeratinzation | |
ATE110255T1 (de) | Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums. | |
DE69131646D1 (de) | Verfahren und mittel zur förderung des haarwuchses und zur verbesserung des hautzustands | |
DE69807538T2 (de) | Vorrichtung und Verfahren zur Behandlung von Gewebe | |
DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
WO2002064088A3 (en) | Pharmaceutical composition for the treatment of alopecia | |
DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
DE69918145D1 (de) | Verwendung von diltiazem zur behandlung von pathologien der netzhaut | |
DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
ATE424843T1 (de) | Verfahren zur verminderung des haarausfalls und förderung des haarwiederwachstums | |
DE69824017D1 (de) | Vehikel zur gentherapie enthaltend dermales huellgewebe | |
DE29812309U1 (de) | Implantat und Vorrichtung zur Behandlung von Implantaten | |
ATE211650T1 (de) | Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen | |
DE69820911D1 (de) | Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren | |
HUP9900007A2 (hu) | Készítmény baromfialom kezelésére | |
ATE358490T1 (de) | Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen | |
DE69729667D1 (de) | Vorrichtung zur behandlung von lenden- und hüftenoberschenkel-organen | |
ATE218869T1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen | |
DE29814987U1 (de) | Vorrichtung zur Stimulation von Körpergewebe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |